A carregar...
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer
The anti-angiogenic agent bevacizumab has been approved for the treatment of non-small cell lung cancer, although the survival benefit associated with this agent is marginal, and toxicities and cost are substantial. A recent screen for selective inhibitors of endothelial cell proliferation identifie...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3206167/ https://ncbi.nlm.nih.gov/pubmed/21896639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0691 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|